Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens

Recruiting Observational Study
Host Defense Mechanisms
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Human phagocytic cells such as polymorphonuclear leukocytes (PMNs) are readily mobilized to sites of infection and ingest microorganisms by a process known as phagocytosis. The combined effects of reactive oxygen species (ROS) and proteolytic peptides and enzymes released into forming bacterial phagosomes kill most ingested bacteria. However, many human bacterial pathogens have devised means to su…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION \& EXCLUSION CRITERIA: Volunteers will be selected from a healthy adult population, 18 years of age or older, with no known medical problems and will generally be NIH employees working at Rocky Mountain Laboratories (RML) or within the community of Hamilton, MT. No race or gender is ex…
Contacts

Frank R De Leo, Ph.D.

(406) 363-9448

fdeleo@niaid.nih.gov

CONTACT